Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy

Fig. 1

Consolidated Standards of Reporting Trials (CONSORT) diagram depicting the entire study cohort. There were 921 patients with a pathologic complete response at our institution during the study period. Two hundred of these patients received part of their chemotherapy at an outside institution. A total of 721 patients were included in survival analyses, and 642 in were included the multivariate analysis

Back to article page
\